Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.770
-0.060 (-2.12%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Nkarta Employees
Nkarta had 108 employees as of December 31, 2025. The number of employees decreased by 49 or -31.21% compared to the previous year.
Employees
108
Change (1Y)
-49
Growth (1Y)
-31.21%
Revenue / Employee
n/a
Profits / Employee
-$963,741
Market Cap
197.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MacroGenics | 293 |
| Karyopharm Therapeutics | 228 |
| MediWound | 121 |
| Caribou Biosciences | 97 |
| OmniAb | 89 |
| Enlivex | 34 |
| Elicio Therapeutics | 33 |
NKTX News
- 13 days ago - Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers - GlobeNewsWire
- 13 days ago - Nkarta Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 19 days ago - Nkarta to Participate in Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 7 weeks ago - Nkarta Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Nkarta Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Nkarta to Participate in March Investor Conferences - GlobeNewsWire
- 5 months ago - Nkarta Transcript: Evercore ISI 8th Annual HealthCONx Conference - Transcripts